NASHVILLE, Tenn. (WTVF) — A new initiative from Harm Reduction Coalition and Gilead Sciences is helping to stop the spread of Hepatitis C.
The opioid crisis has caused a sharp rise in Hep C cases in Tennessee. Hep C is transmitted through blood, and often affects drug users who use dirty needles.
Nearly 70,000 Tennesseans have the disease. But, the new program, HepConnect works to reduce the stigma around opioid use; so that more people get treatment for addiction and Hepatitis.
HepConect is a five-year, multi-million dollar program.